Skip to content

Saturday, October 24, 2026

Top Stories Global Economy Markets Topics & Series Contributors Opinion

All desks ⌄

Economy & Finance

Economy Investing Central Banks Digital Currency Fintech Research & Analysis Technicals

Power & Business

Politics Business Law Insights & Views Governance Market Roundups

Science & Society

Technology Science Nature Health Life

In focus · trending topic

Remibrutinib

1 stories · following the connections

Attendees examine clinical research posters at a medical conference in Toronto, Canada. / EconoTimes.ai

Novartis Drug Lowers Annualized Relapse Rates by Up to 35.2% in MS Trials

By Naomi CalderOct 24, 2026, 2:44 AM UTC

←1→Page 1 of 1

Connected markets

Follow the indicators behind the story.

Illustrative data · 06 Oct 2026, 08:00 UTC

Keep exploring

China Gold Donald Trump Al Jazeera National Park Service Household Spending East Potomac Park Hains Point

Coverage

Global Economy Markets Technology Politics All news

Intelligence

Topics & Series Contributors Research

Company

About us Become a contributor Contact info@econotimes.com Editorial standards

© 2026 PUBLISH Holdings LLC.Privacy Terms of use Our standards

Home Markets Topics Search